bioAffinity Technologies (BIAF) Current Deferred Revenue (2023 - 2026)
bioAffinity Technologies (BIAF) reported Current Deferred Revenue of $31140.0 for Q1 2026, up 27.6% year-over-year from $24404.0 in Q1 2025, and up 30.69% quarter-over-quarter from $23827.0 in Q4 2025.
bioAffinity Technologies (BIAF) Current Deferred Revenue (2023 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has 4 years of Current Deferred Revenue data on file, last reported at $31140.0 in Q1 2026.
- Current Deferred Revenue for Q1 2026 came in at $31140.0, up 27.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $31140.0 (up 27.6% YoY), and the FY2025 annual result was $23827.0, down 2.36% from the prior year.
- Current Deferred Revenue rose to $31140.0 in Q1 2026 per BIAF's latest filing, from $23827.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $42750.0 in Q2 2023 and troughed at $23827.0 in Q4 2025.
- A 4-year average of $30072.1 and a median of $28154.5 in 2024 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2024 and 2025: Current Deferred Revenue tumbled 38.87% in 2024, then surged 55.36% in 2025.
- A 4-year view of Current Deferred Revenue shows it stood at $33058.0 in 2023, then slipped by 26.18% to $24404.0 in 2024, then decreased by 2.36% to $23827.0 in 2025, then soared by 30.69% to $31140.0 in 2026.
- Business Quant data shows BIAF's Current Deferred Revenue at $31140.0 in Q1 2026, $23827.0 in Q4 2025, and $37915.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | bioAffinity Technologies | 2.08 Mn | -1.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31,140.00 |
| Dec 31, 2025 | 23,827.00 |
| Sep 30, 2025 | 37,915.00 |
| Jun 30, 2025 | 24,404.00 |
| Mar 31, 2025 | 24,404.00 |
| Dec 31, 2024 | 24,404.00 |
| Sep 30, 2024 | 24,404.00 |
| Jun 30, 2024 | 26,135.00 |
| Mar 31, 2024 | 30,174.00 |
| Dec 31, 2023 | 33,058.00 |
| Sep 30, 2023 | 38,250.00 |
| Jun 30, 2023 | 42,750.00 |